IOVANCE BIOTHERAPEUTICS INC IOV - stock earnings
0JDK.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -113.8 million USD | 469000 USD |
| 2023Q2 | -106.5 million USD | 238000 USD |
| 2023Q1 | -107.4 million USD | ? USD |
| 2022Q4 | -105.3 million USD | ? USD |
| 2021Q3 | -86.1 million USD | ? USD |
| 2021Q2 | -81.4 million USD | ? USD |
| 2021Q1 | -75.4 million USD | ? USD |
| 2020Q4 | -68.4 million USD | ? USD |
| 2020Q3 | -58.6 million USD | ? USD |
0JDK.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -395.9 million USD | ? USD |
| 2021 | -342.3 million USD | ? USD |
| 2020 | -259.6 million USD | ? USD |
| 2019 | -197.6 million USD | ? USD |
| 2018 | -123.6 million USD | ? USD |
| 2017 | -92.1 million USD | ? USD |
| 2016 | -52.9 million USD | ? USD |
0JDK.L
Price: $10.30
52 week price:
Earnings Per Share: -2.30 USD
P/E Ratio: -3.97
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 18.7 million